c-Myc localization within the nucleus: Evidence for association with the PML nuclear body

Journal of Cellular Biochemistry

Volumn 93, Issue 6, 2004, Pages 1282-1296

  Smith, Kelly P ^a   Byron, Meg ^a   O'Connell, Brenda C ^b   Tam, Rose ^a   Schorl, Christoph ^b   Guney, Isil ^b   Hall, Lisa L ^a   Agrawal, Pooja ^b   Sedivy, John M ^b   Lawrence, Jeanne B ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

C Myc; Max; Nucleus; PML; Proteasomes

Indexed keywords

MAX PROTEIN; MYC PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEASOME INHIBITOR; PROTEIN ANTIBODY; BASIC HELIX LOOP HELIX LEUCINE ZIPPER TRANSCRIPTION FACTOR; BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; BENZYLOXYCARBONYLLEUCYL LEUCYL LEUCINE ALDEHYDE; BENZYLOXYCARBONYLLEUCYL-LEUCYL-LEUCINE ALDEHYDE; DNA BINDING PROTEIN; LEUPEPTIN; MAX PROTEIN, HUMAN; MAX PROTEIN, MOUSE; MAX PROTEIN, RAT; MYC ASSOCIATED FACTOR X; NUCLEAR PROTEIN; PML PROTEIN, HUMAN; PML PROTEIN, MOUSE; PROTEASOME; TRANSCRIPTION FACTOR; TUMOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL NUCLEUS INCLUSION BODY; CELL STRUCTURE; CYTOLOGY; DIPLOIDY; DRUG INHIBITION; FIBROBLAST; GRANULAR CELL; NONHUMAN; NUCLEOLUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; UBIQUITINATION; ANIMAL; CELL NUCLEUS; DRUG ANTAGONISM; GENETIC TRANSFECTION; GENETICS; HELA CELL; HETEROZYGOTE; HOMOZYGOTE; HUMAN; METABOLISM; MOUSE; MOUSE MUTANT; PHYSIOLOGY; RAT; ULTRASTRUCTURE;

ANIMALS; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CELL NUCLEOLUS; CELL NUCLEUS; DIPLOIDY; DNA-BINDING PROTEINS; FIBROBLASTS; HELA CELLS; HETEROZYGOTE; HOMOZYGOTE; HUMANS; INTRANUCLEAR INCLUSION BODIES; LEUPEPTINS; MICE; MICE, KNOCKOUT; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTO-ONCOGENE PROTEINS C-MYC; RATS; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

EID: 21644467027     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20273     Document Type: Article

References (51)

1. Abrams HD, Rohrschneider LR, Eisenman RN. 1982. Nuclear location of the putative transforming protein of avian myelocytomatosis virus. Cell 29:427-439.
2. Amati B, Frank SR, Donjerkovic D, Taubert S. 2001. Function of the c-Myc oncoprotein in chromatin remodeling and transcription. Biochim Biophys Acta 1471: M135-M145.
3. Anton LC, Schubert U, Bacik I, Princiotta MF, Wearsch PA, Gibbs J, Day PM, Realini C, Rechsteiner MC, Bennink JR, Yewdell JW. 1999. Intracellular localization of proteasomal degradation of a viral antigen. J Cell Biol 146:113-124.
4. Arabi A, Rustum C, Hallberg E, Wright AP. 2003. Accumulation of c-Myc and proteasomes at the nucleoli of cells containing elevated c-Myc protein levels. J Cell Sci 116:1707-1717.
5. Ascoli CA, Maul GG. 1991. Identification of a novel nuclear domain. J Cell Biol 112:785-795.
6. Baudino TA, Cleveland JL. 2001. The Max network gone mad. Mol Cell Biol 21:691-702.
7. Borden KL, Boddy MN, Lally J, O'Reilly NJ, Martin S, Howe K, Solomon E, Freemont PS. 1995. The solution structure of the RING finger domain from the acute promyelocytic leukaemia proto-oncoprotein PML. EMBO J 14:1532-1541.
8. Claassen GF, Hann SR. 1999. Myc-mediated transformation: The repression connection. Oncogene 18:2925-2933.
9. Cole MD, McMahon SB. 1999. The Myc oncoprotein: A critical evaluation of transactivation and target gene regulation. Oncogene 18:2916-2924.
10. Darzacq X, Jady BE, Verheggen C, Kiss AM, Bertrand E, Kiss T. 2002. Cajal body-specific small nuclear RNAs: A novel class of 2′-O-methylation and pseudouridylation guide RNAs. EMBO J 21:2746-2756.
11. Dimberg A, Bahram F, Karlberg I, Larsson LG, Nilsson K, Oberg F. 2002. Retinoic acid-induced cell cycle arrest of human myeloid cell lines is associated with sequential down-regulation of c-Myc and cyclin E and posttranscriptional up-regulation of p27(Kip1). Blood 99:2199-2206.
12. Dyck JA, Maul GG, Miller J, Miller WH, Chen JD, Kakikuza A, Evans RM. 1994. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 76:333-343.
13. Everett RD. 2000. ICP0 induces the accumulation of colocalizing conjugated ubiquitin. J Virol 74:9994-10005.
14. Everett RD, Meredith M, Orr A, Cross A, Kathoria M, Parkinson J. 1997. A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein. EMBO J 16:1519-1530.
15. Fabunmi RP, Wigley WC, Thomas PJ, DeMartino GN. 2001. Interferon gamma regulates accumulation of the proteasome activator PA28 and immunoproteasomes at nuclear PML bodies. J Cell Sci 114:29-36.
16. Gall JG. 2000. Cajal bodies: The first 100 years. Annu Rev Cell Dev Biol 16:273-300.
17. Gross-Mesilaty S, Reinstein E, Bercovich B, Tobias KE, Schwartz AL, Kahana C, Ciechanover A. 1998. Basal and human papillomavirus E6 oncoprotein-induced degradation of Myc proteins by the ubiquitin pathway. Proc Natl Acad Sci USA 95:8058-8063.
18. Hann SR, Abrams HD, Rohrschneider LR, Eisenman RN. 1983. Proteins encoded by v-myc and c-myc oncogenes: Identification and localization in acute leukemia virus transformants and bursal lymphoma cell lines. Cell 34:789-798.
19. Henriksson M, Classon M, Axelson H, Klein G, Thyberg J. 1992. Nuclear colocalization of c-myc protein and hsp70 in cells transfected with human wild-type and mutant c-myc genes. Exp Cell Res 203:383-394.
20. Henriksson M, Classon M, Ingvarsson S, Koskinen P, Sumegi J, Klein G, Thyberg J. 1988. Elevated expression of c-myc and N-myc produces distinct changes in nuclear fine structure and chromatin organization. Oncogene 3:587-593.
21. Henriksson M, Luscher B. 1996. Proteins of the Myc network: Essential regulators of cell growth and differentiation. Adv Cancer Res 68:109-182.
22. Hershko A, Ciechanover A. 1998. The ubiquitin system. Annu Rev Biochem 67:425-479.
23. Klibanov SA, O'Hagan HM, Ljungman M. 2001. Accumulation of soluble and nucleolar-associated p53 proteins following cellular stress. J Cell Sci 114:1867-1873.
24. Kretzner L, Blackwood EM, Eisenman RN. 1992. Myc and Max proteins possess distinct transcriptional activities. Nature 359:426-429.
25. Kurz A, Lampel S, Nickolencko JE, Bradl J, Benner A, Zirbel RM, Lichter P. 1996. Active and inactive genes localize to the periphery of chromosome territories. J Cell Biol 135:1195-1205.
26. Lallemand-Breitenbach V, Zhu J, Puvion F, Koken M, Honore N, Doubeikovsky A, Duprez E, Pandolfi PP, Puvion E, Freemont P, de The H. 2001. Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, US proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation. J Exp Med 193:1361-1371.
27. Lamond AI, Earnshaw WC. 1998. Structure and function in the nucleus. Science 280:547.
28. Mateyak MK, Obaya AJ, Adachi S, Sedivy JM. 1997. Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination. Cell Growth Differ 8:1039-1048.
29. Mateyak MK, Obaya AJ, Sedivy JM. 1999. c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points. Mol Cell Biol 19:4672-4683.
30. Mattsson K, Pokrovskaja K, Kiss C, Klein G, Szekely L. 2001. Proteins associated with the promyelocytic leukemia gene product (PML)-containing nuclear body move to the nucleolus upon inhibition of proteasome-dependent protein degradation. Proc Natl Acad Sci USA 98:1012-1017.
31. Miller AD, Miller DG, Garcia JV, Lynch CM. 1993. Use of retroviral vectors for gene transfer and expression. Methods Enzymol 217:581-599.
32. Moen PT, Smith KP, Lawrence JB. 1995. Compartmentalization of specific pre-mRNA metabolism: An emerging view. Hum Mol Genet 4:1779-1789.
33. Pear WS, Nolan GP, Scott ML, Baltimore D. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci USA 90:8392-8396.
34. Pokrovskaja K, Mattsson K, Kashuba E, Klein G, Szekely L. 2001. Proteasome inhibitor induces nucleolar translocation of Epstein-Barr virus-encoded EBNA-5. J Gen Virol 82:345-358.
35. Prouty SM, Hanson KD, Boyle AL, Brown JR, Shichiri M, Follansbee MR, Kang W, Sedivy JM. 1993. A cell culture model system for genetic analyses of the cell cycle by targeted homologous recombination. Oncogene 8:899-907.
36. Ramsay G, Stanton L, Schwab M, Bishop JM. 1986. Human proto-oncogene N-myc encodes nuclear proteins that bind DNA. Mol Cell Biol 6:4450-4457.
37. Reyes JC. 2001. PML and COP1-two proteins with much in common. Trends Biochem Sci 26:18-20.
38. Salghetti SE, Kim SY, Tansey WP. 1999. Destruction of Myc by ubiquitin-mediated proteolysis: Cancer-associated and transforming mutations stabilize Myc. EMBO J 18:717-726.
39. Salomoni P, Pandolfi PP. 2002. The role of PML in tumor suppression. Cell 108:165-170.
40. Sears R, Leone G, DeGregori J, Nevins JR. 1999. Ras enhances Myc protein stability. Mol Cell 3:169-179.
41. 1 transition in nontransformed cells. Cell Growth Differ 4:93-104.
42. Shopland LS, Lawrence JB. 2000. Seeking common ground in nuclear complexity [comment]. J Cell Biol 150:F1-F4.
43. Spector DL, Watt RA, Sullivan NF. 1987. The v- and c-myc oncogene proteins colocalize in situ with small nuclear ribonucleoprotein particles. Oncogene 1:5-12.
44. Sullivan NF, Watt RA, Delannoy MR, Green CL, Spector DL. 1986. Colocalization of the myc oncogene protein and small nuclear ribonucleoprotein particles. Cold Spring Harb Symp Quant Biol 51:943-947.
45. Tam R, Johnson C, Shopland L, McNeil J, Lawrence JB. 2002. Applications of RNA FISH for visualizing gene expression and nuclear architecture. In: Beatty B, Mai S, Squire J, editors. FISH. Oxford: Oxford University Press, p 93-118.
46. Tworkowski KA, Salghetti SE, Tansey WP. 2002. Stable and unstable pools of Myc protein exist in human cells. Oncogene 21:8515-8520.
47. Waters CM, Littlewood TD, Hancock DC, Moore JP, Evan GI. 1991. c-myc protein expression in untransformed fibroblasts. Oncogene 6:797-805.
48. Weis K, Rambaud S, Lavau C, Jansen J, Carvalho T, Carmo-Fonseca M, Lamond A, Dejean A. 1994. Retinoic acid regulates aberrant nuclear localization of PML-RARalpha in acute promyelocytic leukemia cells. Cell 76:345-356.
49. Wojcik C, DeMartino GN. 2003. Intracellular localization of proteasomes. Int J Biochem Cell Biol 35:579-589.
50. Yin X, Landay MF, Han W, Levitan ES, Watkins SC, Levenson RM, Farkas DL, Prochownik EV. 2001. Dynamic in vivo interactions among Myc network members. Oncogene 20:4650-4664.
51. Zhong S, Salomoni P, Pandolfi PP. 2000. The transcriptional role of PML and the nuclear body. Nat Cell Biol 2: E85-E90.